NCT02428439

Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression

Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 80 (estimated)
• Sponsor: Asan Medical Center · Academic / Other
• Sex: All
• Age: 11 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to identification of genetic markers and predictors of antidepressant-induced suicidality in youth depression. Participants who take the standardized pharmacotherapy (bupropion or lamotrigine) for depression will be observed for 8 weeks. They will do several scales and genetic tests at visit 1 (week 0), visit 3 (week 4) and visit 4 (week 8)

Conditions

• Depression
• Suicidal Ideation

Interventions

Type	Name	Description
DRUG	bupropion or lamotrigine	Participants who take the standardized pharmacotherapy (bupropion or lamotrigine) for depression will be observed for 8 weeks. Drugs using in this study are the standard treatment for depression, and are NOT administered as part of this study.

Timeline

• Start date: 2015-04-01
• Primary completion: 2019-12-31
• Completion: 2020-06-30
• First posted: 2015-04-28
• Last updated: 2019-07-05

Locations

1 site across 1 country: South Korea